Código QR

Mesenchymal Stromal Cells: Potential Option for COVID-19 Treatment

The COVID-19 pandemic has significantly impacted the way of life worldwide and continues to bring high mortality rates to at-risk groups. Patients who develop severe COVID-19 pneumonia, often complicated with ARDS, are left with limited treatment options with no targeted therapy currently available....

Descrición completa

Gardado en:
Principais autores: Dragan Primorac, Martin Čemerin, Vid Matišić, Vilim Molnar, Marko Strbad, Lenart Girandon, Lucija Zenić, Miomir Knežević, Stephen Minger, Denis Polančec
Formato: Artigo
Idioma:Inglês
Publicado: MDPI AG 2021-09-01
Series:Pharmaceutics
Assuntos:
COVID-19
mesenchymal stromal cells
MSCs
immunomodulation
ARDS
Acceso en liña:https://www.mdpi.com/1999-4923/13/9/1481
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares